Description:

E3F05 Second Primary Form Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7004D1D0-8F94-615D-E040-BB89AD436FDA

Keywords:

Brain Neoplasms

Central Nervous System Neoplasms

Uploaded on:

August 26, 2012

DOI:

To request one please log in.

License :

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Brain and Central Nervous System Tumors NCT00978458 Registration - E3F05 Second Primary Form - 2926619v1.0

Details

INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

1 forms

StudyEvent: E3F05 Second Primary Form
1. INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

Unnamed1

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

DCI Name

Registration Step

Reporting Period

Second Primary Cancer (Second Primary)

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

Unnamed2

Patient Initials (Last, First)

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

Participating Group Protocol Number

Institution/Affiliate

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

Participating Group Patient ID

Unnamed3

Please mark an 'X' if data have been amended. (Please circle amended items in red)

Date data amended (s M D Y)

Unnamed3

Date of Diagnosis of Second Primary Cancer (M D Y)

Site of Second Primary Cancer

Include information on histologic subtype (s Please attach copies of any corroborating pathology reports)

ECOG Protocol Number (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

ECOG Patient ID (If patient has been on other therapeutic ECOG protocols, please list protocols and patient ID numbers)

Briefly describe cancer therapy the patient has received prior to the diagnosis of the second primary and other than that given on ECOG protocols

Briefly describe treatment planned or given for the diagnosis of this second primary

Comments

Investigator Signature

Investigator Signature Date (M D Y)

Back to the top of the page

Similar models

Show recommended models

Description:

Link:

Keywords:

Versions (3)

Uploaded on:

DOI:

License :

Model comments :

Itemgroup comments for :

Item comments for :

Brain and Central Nervous System Tumors NCT00978458 Registration - E3F05 Second Primary Form - 2926619v1.0

INSTRUCTIONS: This form is to be completed and submitted within 30 days of diagnosis of a new primary cancer for patients previously treated on NCI/CTEP sponsored protocols. If the patient has been diagnosed with AML/MDS, please complete and submit the NCI/CTEP Secondary AML/MDS Report Form instead

Similar models

Contact

Help